CMS MS-DRG · Major Diagnostic Category

MDC 17 — Myeloproliferative diseases and disorders, and poorly differentiated neoplasms — Medicare DRGs

28 DRGs · 53,085 discharges · FY2024 (Oct–Sep) Medicare fee-for-service Part A

847 · CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC 8,352 discharges › 840 · LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC 8,191 discharges › 841 · LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC 5,419 discharges › 834 · ACUTE LEUKEMIA WITH MCC 4,255 discharges › 846 · CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC 3,445 discharges › 823 · LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC 2,474 discharges › 843 · OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MC 2,281 discharges › 829 · MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WI 1,888 discharges › 824 · LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC 1,887 discharges › 837 · CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY A 1,776 discharges › 827 · MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDUR 1,653 discharges › 835 · ACUTE LEUKEMIA WITH CC 1,646 discharges › 844 · OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC 1,355 discharges › 838 · CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAP 1,240 discharges › 820 · LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC 1,068 discharges › 828 · MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDUR 997 discharges › 821 · LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC 890 discharges › 826 · MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDUR 871 discharges › 842 · LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC 760 discharges › 822 · LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC 661 discharges › 825 · LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC 424 discharges › 839 · CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 410 discharges › 830 · MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WI 300 discharges › 849 · RADIOTHERAPY 285 discharges › 836 · ACUTE LEUKEMIA WITHOUT CC/MCC 195 discharges › 845 · OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT 164 discharges › 848 · CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 103 discharges › 850 · ACUTE LEUKEMIA WITH OTHER PROCEDURES 95 discharges ›

Each row opens that DRG's national market — discharges, state breakdown, and (for a subscriber) charge and payment figures. Discharges are counted stays reported to Medicare fee-for-service Part A (no Medicare Advantage), Maryland waiver-priced.